Medtronic Infuse Bone Graft Claims Being Investigated By Bernstein Liebhard LLP

Share Article

Medtronic Infuse bone graft lawsuits brought on behalf of individuals who allegedly sustained injuries, such as respiratory nerve damage, cancer and/or death are currently being evaluated by Bernstein Liebhard LLP.

Bernstein Liebhard LLP | Consumer Injury Lawyers
The FDA has received 280 adverse event reports relating to the Medtronic Infuse bone graft – three-quarters of those reports involved off-label use.

Medtronic Infuse bone graft is a bone-growth protein used off-label to treat cervical spine conditions. It is also used in lower back procedures, certain dental procedures, tibia repair and degenerative disc disease repair. Although the Medtronic Infuse bone graft was approved by the U.S. Food and Drug Administration (“FDA”) in 2002 to treat the latter conditions, it has not been approved for use during cervical spine surgeries. The FDA has received 280 adverse event reports relating to the Medtronic Infuse bone graft – three-quarters of those reports involved off-label use. When used off-label in cervical spine surgeries, it has been associated with serious side effects, including:

  •     difficulty breathing;
  •     difficulty swallowing;
  •     compression of the airway requiring hospitalization;
  •     nerve damage requiring ongoing treatment; or
  •     death within one month of the procedure.

Bernstein Liebhard LLP, a New York law firm nationally recognized for its consumer protection and mass tort practices, is currently evaluating lawsuits on behalf of individuals who may have suffered Medtronic Infuse bone graft injuries.

Medtronic Infuse Bone Graft Bone Growth Cancer Link

In addition to complications resulting from the off-label use of the protein, other injuries are emerging even where the Medtronic Infuse bone graft is used to treat non-cervical spine conditions. These injuries include:

  •     unresolved radiating leg pain;
  •     nerve damage requiring ongoing treatment;
  •     retrograde ejaculation (which can cause sterility);
  •     cancer; or
  •     uncontrolled bone growth.

It is estimated that as many as 100,000 patients a year have been treated with the Medtronic Infuse bone graft. Given the severity of these side effects, the lawyers at Bernstein Liebhard LLP are offering free and confidential case evaluations to individuals who may have experienced complications or developed cancer after receiving the Medtronic Infuse bone graft during surgery.

Those who received an Infuse bone graft during surgery and suffered side effects may be entitled to compensation for medical bills, pain and suffering, lost wages and other injuries. For more information about filing a lawsuit, visit You can also contact an attorney at Bernstein Liebhard LLP at (877) 779-1414.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past nine consecutive years. Only two firms in the country have been selected for the Hot List nine years in a row.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website